ORLANDO, Fla., Nov. 13, 2011 (GLOBE NEWSWIRE) -- Administering a platelet inhibitor directly into a blocked coronary artery was no more effective than intravenous delivery in improving overall health outcomes in severe heart attack patients, according to late-breaking research presented at the American Heart Association’s Scientific Sessions 2011.